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SH2 domains are common protein interaction domains able to recognize short
aminoacidic sequences presenting a phosphorylated tyrosine (pY). In spite of their
fundamental importance for cell physiology there is a lack of information about
the mechanism by which these domains recognize and bind their natural ligands.
The N-terminal SH2 (N-SH2) domain of PI3K mediates the interaction with different
scaffolding proteins and is known to recognize a specific pY-X-X-M consensus
sequence. These interactions are at the cross roads of different molecular pathways and
play a key role for cell development and division. By combining mutagenesis, chemical
kinetics and NMR, here we provide a complete characterization of the interaction
between N-SH2 and a peptide mimicking the scaffolding protein Gab2. Our results
highlight that N-SH2 is characterized by a remarkable structural plasticity, with the
binding reaction being mediated by a diffused structural region and not solely by the
residues located in the binding pocket. Furthermore, the analysis of kinetic data allow us
to pinpoint an allosteric network involving residues far from the binding pocket involved in
specificity. Results are discussed on the light of previous works on the binding properties
of SH2 domains.
Keywords: allosteric network, skinetics, mutagenesis, peptide binding, NMR
INTRODUCTION
The interaction between proteins plays a paramount role in biological functions. Frequently,
protein-protein recognition is mediated by specific domains such as SH2, SH3, WW, or PDZ
domains (Macias et al., 1996; Pawson and Scott, 1997; Bhattacharyya et al., 2006; Teyra et al.,
2012; Kurochkina and Guha, 2013). Whilst these domains are typically highly conserved and often
very abundant in the cellular environment, they are nevertheless specific, such as cross-reactivity
with non-desired partners is minimized (Zarrinpar et al., 2003). It has been observed that PDZ
and SH3 domains control their ability to recognize specific consensus sequences through dynamic
and energetic allosteric mechanisms (Lockless and Ranganathan, 1999; Fuentes et al., 2006; Gianni
et al., 2011; Kumawat and Chakrabarty, 2017; Malagrinò et al., 2019). These mechanisms overcome
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the classical paradigm of allostery, which is based on major
protein structural and conformational changes, and are
characterized by fine rearrangement in the dynamic of the
system (Kern and Zuiderweg, 2003; Motlagh et al., 2014). This
behavior has been demonstrated for different protein-protein
interaction domains. However, despite their critical roles in many
important biological pathways, little information is currently
available on Src Homology 2 (SH2) domains, for which only little
evidence of interdomain allosteric regulations has been reported
(Tsutsui et al., 2016; Gangopadhyay et al., 2020).
SH2 domains represent a classical example of modular
protein interaction domains. SH2 domains are present in a
wide range of proteins, including kinases, adaptors, phosphatases
and other signaling molecules (Songyang et al., 1993; Payne
et al., 1994), counting for more than 110 different proteins
encoded by human genome. From a structural point of view,
the SH2 domains are composed of about 100 amino acids
presenting a conserved architecture comprising three to seven
anti-parallel β strands organized in a β sheet, flanked by two
α-helices (Waksman et al., 1992, 1993). SH2 domains from
different proteins are known to recognize specific consensus
sequences containing a phosphorylated tyrosine (pY) (Payne
et al., 1994). In addition to the phospho-tyrosine, each SH2
domain recognizes several additional flanking residues, generally
three to five amino acids C-terminal to pY (Schaffhausen, 1995).
Many signaling pathways require the action of SH2 domains
to control the colocalization of a variety of proteins within the
signaling cascade, the binding events mediated by these domains
allowing a correct signal transduction (Koch et al., 1991; Neel
et al., 2003). For these reasons, mutations that affect the binding
properties of the SH2 domains lead to an abnormal regulation
of important signaling pathways, causing the misregulation of
key physiological processes in the cell and consequently to the
development of a number of diseases (Tartaglia et al., 2001;
Lappalainen et al., 2008).
PI3K proteins interact with various RTKs involved
in an ample range of signaling processes (Katso et al.,
2001; Engelman et al., 2006). The activation of PI3K
requires the interaction of its two SH2 domains with
the binding partners, thus driving the phosphorylation of
phosphatidylinositols at their 3′ position. Both the N-terminal
and the C-terminal SH2 domains (N-SH2 and C-SH2
respectively) recognize the consensus pY-X-X-M sequence
of the target (Waksman et al., 1992; Songyang et al., 1993).
The interaction between PI3K and their ligands is very often
mediated by scaffolding proteins like, for example, Gab1,
Gab2, IRS-1, FRS2, that act as platforms recruiting several
transcription factors and allowing the correct formation of the
molecular machinery.
The Grb2-associated binding protein (Gab2) is composed
by an N-terminal folded PH domain and C-terminal unfolded
region where the binding sites for other signaling proteins are
situated. Because of its key role as scaffolding protein and in the
binding with several transcription factors, Gab2 is implicated in
several cancers of both solid and hematological origin (Ke et al.,
2007; Ding et al., 2015). In particular Gab2 is overexpressed in
breast (Bentires-Alj et al., 2006), gastric (Lee et al., 2007) and lung
(Xu et al., 2011) cancers, while its expression in healthy mature
cells is relatively suppressed.
Here we provide, through a combination of stopped-flow and
NMR experiments, a detailed characterization of the interaction
between the N-terminal SH2 domain of PI3K and a 13-residue
peptide mimicking Gab2, in its wild-type form and a variant
M→A affecting the specific consensus pY-X-X-M sequence.
Whilst the structural features of the N-SH2 has been previously
described both in the free and in the bound state with other
partners (Nolte et al., 1996), the mechanism of interaction of
this protein with its natural ligands has never been characterized.
Our data show that N-SH2 displays an unexpected structural
plasticity, which does not reflect as major structural changes
upon binding, but as a finely regulated rearrangement of the
entire domain. Binding capabilities of N-SH2 are not solely
mediated by its binding pocket but are modulated diffusely within
its structure. In fact, by combining site-directed mutagenesis
with kinetic and NMR experiments we provide compelling
evidence highlighting a remarkable structural malleability of
N-SH2 domain. The analysis of kinetic data allowed us to depict
an allosteric network involving residues that are not located in
the binding site but nevertheless appear to play a role in the
recognition of the M residue, which is part of the consensus
sequence of N-SH2. These results provide the first description of
an allosteric network in the binding reaction of a SH2 domain.
MATERIALS AND METHODS
Protein Expression and Purification
N-SH2 wild-type and all the site-directed variants were
expressed and purified as described previously (Visconti et al.,
2019). All the mutants were obtained using a QuickChange
Lightning Site-Directed Mutagenesis kit (Agilent technologies),
accordingly to manufacturer instructions. Peptides with
sequence TNSEDNpYVPMNPG mimicking wild-type Gab2 and
TNSEDNpYVPANPG mimicking the M457A variant of Gab2
were purchased from GenScript Biotech Corporation.
Stopped-Flow Experiments
Binding kinetics experiments were performed using a single-
mixing SX-18 stopped-flow instrument (Applied Photophysics);
all binding experiments were conducted in 50 mM Hepes
pH 7.4 300 mM NaCl at 10◦C. Excitation was at 280 nM
and emission was collected using a 475 nM cut-off glass
filter. Pseudo-first order binding experiments were performed
mixing a constant concentration of dansylated Gab2448−460 and
Gab2448−460 M457A (1 µM) vs. N-SH2 wt and its mutants
at concentrations ranging from 4 to 12 µM. For each N-SH2
concentration, usually 5 individual traces were averaged and in
all cases the fluorescence time courses obtained was satisfactorily
fitted by using a single exponential equation.
NMR Experiments
Standard triple resonance experiments [CBCA(CO)NH,
HNCACB, HNCO, HN(CA)CO spectra] and HSQC were
recorded at 10◦C on Bruker spectrometers operating at 1H
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frequencies of 600 MHz. Solution NMR experiments were
carried out in buffer 50 mM Hepes pH 7.4 300 mM NaCl using
a 100 µM sample of labeled N-SH2. For the full assignment of
the bound N-SH2 we performed titrations of 1H-15N HSQC
spectra of a 100 µM sample of N-SH2 with both Gab2448−460
and Gab2448−460 M457A, which were recorded using progressive
concentration of the ligand until 1:1 molar ratio.
RESULTS
Stopped-Flow Binding Kinetics
One of the aims of this study is to depict the molecular details of
the interaction between the N-SH2 domain of PI3K and Gab2.
A powerful strategy to achieve this goal relies on perturbing
the system by producing conservative site-directed variants
while monitoring the effect of mutations on the association
and dissociation rate constants between the interacting partners
(kon and koff respectively). Thus, we designed and successfully
produced 21 site-directed variants of the N-SH2 domain and
challenged them vs. a peptide mimicking the region of Gab2
ranging from residue 448–460 (Gab2448−460), containing the
pY-X-X-M motif that is specifically recognized by the N-SH2
domain (Waksman et al., 1992; Songyang et al., 1993). The
choise of mutations was designed in analogy to phi-value analysis
methodology in protein folding studies (Fersht and Sato, 2004).
Positions mutated are showed in Figure 1. To monitor binding
by fluorescence, a dansyl group was added at the N-terminus of
the peptide. The binding reaction was monitored by stopped-
flow experiments following the change in FRET signal, taking
advantage of the two Trp residues on the N-SH2 domain in
positions 12 and 14 as fluorescence donor and the dansyl group
on Gab2448−460 as acceptor. The experiments were performed
in pseudo-first order conditions with Gab2448−460 at fixed
concentration of 1 µM rapidly mixed vs. large excess of N-SH2 wt
and its variants, ranging from 4 to 14 µM, in buffer Hepes 50 mM,
NaCl 300 mM, pH 7.4, at 10◦C. For all the experiments observed
time courses were found to be consistent with a single exponential
equation. The dependence of observed rate constants kobs as a
function of the concentration of N-SH2 was fitted with a linear
equation, suggesting that the binding reaction can be described
by a simple two-state mechanism
kobs = [NSH2]kon + koff
with kon being the slope of the line and koff the intercept
with the y-axis. Since indirect calculation of koff obtained by
extrapolation is associated with high experimental error, we
performed displacement experiments to directly measure koff by
challenging a pre-incubated complex of dansylated Gab2448−460
and N-SH2 domain both at the concentration of 1 µM vs.
a large excess of non-dansylated Gab2448−460 (50 µM). The
pseudo-first order plots of kobs vs. the concentration of wild-
type N-SH2 and its variants are shown in Figure 2A. Kinetic
parameters extracted from data together with the calculated
changes in activation and equilibrium free energies are reported
in Table 1. Analysis of kinetic data highlights that T48S,
FIGURE 1 | Three dimensional structure of the N-terminal SH2 domain of
PI3K (PDB: 2IUH). Selected positions mutated for the kinetic analysis are
highlighted as blue sticks and spheres.
L51A, and L59A variations cause a detectable decrease of the
affinity of the domain for Gab2448−460 of ∼10-fold, affecting
both the kon and koff. Furthermore, L99A mutation displays a
strong destabilization effect on the complex, with an increase
of dissociation equilibrium rate constant, KD, of ˜100-fold,
mainly caused by a high increase of koff. Since L99 residue is
part of the binding pocket, this dramatic effect on the binding
affinity is expected.
SH2 domains bind ligands with a phosphorylated tyrosine
in their sequence. The N-SH2 domain of PI3K is known
to recognize a specific consensus sequences that present a
methionine in position +3 in respect to the phosphotyrosine
(M457 in Gab2). To investigate the details of the role of
M457 of Gab2 in the binding reaction we conducted kinetic
binding experiments between Gab2448−460 M457A and all
the site-directed variants of N-SH2 domains, under the same
experimental conditions that were used for Gab2448−460. In
analogy to what observed with the wild-type peptide, the
fluorescence change upon binding followed a single exponential
decay, and dependences of kobs vs. the concentration of
N-SH2 were fitted with a linear equation (Figure 2B). Kinetic
data obtained from binding and displacement experiments are
reported in Table 1. Our data show that M457 is not essential
for binding, the KD obtained for the complex with N-SH2 wt
being 3.7 ± 0.4 µM. The analysis of microscopic association and
dissociation rate contants highlights that kon is comparable with
the one calculated for the binding with Gab2448−460. However,
a clear increase in koff is reported for the binding with N-SH2
wt (Gab2448−460 koff = 3.9 ± 0.2 s−1; Gab2448−460 M457A
koff = 80 ± 4 s−1) suggesting that M457 has a role in the
dissociation of Gab2 with N-SH2, rather than in the recognition
event. Interestingly, the kon values obtained for the binding of
Gab2448−460 M457A with all N-SH2 variants appear to be mostly
unaffected by mutations occurring in N-SH2, whilst a more
pronounced effect on the association rate constant is appreciable
for the binding with wild type Gab2448−460. This difference
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TABLE 1 | Kinetic and thermodynamic parameters obtained from the analysis of the pseudo-first order binding experiments between site-directed variants of N-SH2 and Gab2448−460 wild-type and
Gab2448−460 M457A.
Gab2448−460 Gab2448−460 M457A
N-SH2 variant kon (µM−1 s−1) koff (s−1) KD (µM) 11Geq (kcal mol−1) kon (µM−1 s−1) koff (s−1) KD (µM) 11Geq (kcal mol−1) 111 G
WT 19.5 ± 1.0 3.9 ± 0.2 0.2 ± 0.1 21.5 ± 2.4 80 ± 4 3.7 ± 0.4
L7A 15.7 ± 1.2 4.0 ± 0.2 0.3 ± 0.1 0.15 ± 0.03 19.3 ± 2.3 90 ± 4 4.6 ± 0.6 0.12 ± 0.01 **
I17V 24.4 ± 1.7 4.5 ± 0.2 0.2 ± 0.1 −0.05 ± 0.02 22.0± 2.3 90 ± 5 4.3 ± 0.5 0.09 ± 0.01 **
V22A 11.2 ± 0.4 7.4 ± 0.4 0.7 ± 0.1 0.68 ± 0.04 17.7± 2.6 170 ± 9 9.7 ± 1.5 0.55 ± 0.05 **
T29S 17.5 ± 0.5 4.3 ± 0.2 0.3 ± 0.1 0.13 ± 0.02 19.7± 2.7 80 ± 4 4.0 ± 0.6 0.05 ± 0.01 **
A30G 29.2 ± 2.0 3.7 ± 0.2 0.1 ± 0.1 −0.25 ± 0.02 17.1 ± 2.2 90 ± 4 5.1 ± 0.7 0.19 ± 0.10 **
T33S 22.6 ± 2.4 3.6 ± 0.2 0.2 ± 0.1 −0.12 ± 0.02 20.6 ± 2.9 80 ± 4 3.8 ± 0.6 0.02 ± 0.01 **
L35A 7.0 ± 0.6 6.7 ± 0.3 1.0 ± 0.1 0.88 ± 0.09 * * * * *
T48S 6.4 ± 0.5 23 ± 1 3.7 ± 0.1 1.64 ± 0.36 * * * * *
T50S 15.6 ± 0.8 9.3 ± 0.5 0.6 ± 0.1 0.62 ± 0.05 20.2± 2.0 140 ± 7 6.8± 0.8 0.35 ± 0.10 **
L51A 5.6 ± 1.1 18 ± 1 3.2 ± 0.2 1.56 ± 0.64 21.2± 3.3 160 ± 8 7.6 ± 1.2 0.41 ± 0.10 1.16 ± 0.42
L59A 6.7 ± 1.0 21 ± 1 3.2 ± 0.2 1.57 ± 0.52 * * * * *
I60V 9.1 ± 1.1 6.9 ± 0.3 0.8 ± 0.1 0.76 ± 0.10 15.2± 1.5 80 ± 4 5.0 ± 0.6 0.18 ± 0.02 0.58 ± 0.16
I62V 15.5 ± 1.4 4.5 ± 0.2 0.3 ± 0.1 0.21 ± 0.03 18.4± 1.5 120 ± 6 6.7 ± 0.6 0.34 ± 0.10 **
P74A 48.7 ± 1.5 27 ± 1 0.6 ± 0.1 0.59 ± 0.04 22.5± 1.9 60 ± 3 2.6 ± 0.3 −0.20 ± 0.02 0.79 ± 0.12
L75A 8.1 ± 1.1 6.1 ± 0.3 0.8 ± 0.1 0.76 ± 0.11 18.8± 3.2 110 ± 5 5.7 ± 1.0 0.25 ± 0.03 0.51 ± 0.17
T76S 16.9 ± 1.3 5.3 ± 0.3 0.3 ± 0.1 0.26 ± 0.03 19.6± 2.6 100 ± 5 5.0 ± 0.7 0.17 ± 0.02 **
V80A 16.0 ± 1.2 4.4 ± 0.2 0.3 ± 0.1 0.19 ± 0.03 22.3 ± 5.4 130 ± 6 5.6 ± 1.4 0.24 ± 0.02 **
V81A 12.0 ± 1.4 4.5 ± 0.2 0.4 ± 0.1 0.37 ± 0.05 20.5± 3.8 90 ± 5 4.5 ± 0.9 0.11 ± 0.01 **
L99A 8.2 ± 1.7 160 ± 10 20 ± 0.2 2.59 ± 0.30 * * * * *
V101A 13.4 ± 0.4 7.0 ± 0.4 0.5 ± 0.1 0.55 ± 0.06 14.2 ± 1.7 170 ± 9 12 ± 1 0.68 ± 0.10 **
L104A 16.5 ± 0.2 3.5 ± 0.2 0.2 ± 0.1 0.05 ± 0.02 22.1 ± 1.4 110 ± 6 5.2 ± 0.4 0.19 ± 0.02 **
*Binding was abolished by this mutation. **The absolute value of calculated 111G was below 0.4 kcal mol−1 and was excluded from analysis.
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FIGURE 2 | Pseudo first order binding experiments between N-SH2 in its wt form (black circles) and its variants (gray circles) vs Gab2448-460 (A) and Gab2448-460
M457A (B). Black continuous lines for N-SH2 wt and gray broken lines for N-SH2 variants represent the best fit to a linear equation (see text for details).
may suggest that M457 may be energetically connected with
the residues on N-SH2 displaying a different behavior, possibly
highlighting a complex role in the binding reaction with the
N-SH2 and, therefore, demanding further investigations.
LFER Analysis and Characterization of
TS of the Binding Reaction
An essential element to characterize the mechanism of the
binding reaction of a domain is the analysis of the transition
state (TS) of the reaction. In this context, the study of the
correlation between the free energy of the activation barrier
to that of the ground states, classically denoted as linear free
energy relationship plot (LFER plot) (Leffler, 1953), is a widely
used strategy in organic chemistry to analyse reactions involving
formation of covalent bonds, as well as in enzymology (Toney
and Kirsch, 1989), protein folding (Fersht, 2004), and binding
studies (Eaton et al., 1991). LFER analysis correlates the changes
in free energy of the transition state to the changes in equilibrium
free energies; the slope of the correlation being denoted as α
representing the position of the transition state along the reaction
coordinate. The mutational analysis performed in Table 1,
allowed us to apply a LFER analysis on the interaction of
N-SH2 with Gab2448−460 and Gab2448−460 M457A (Figure 3).
Interestingly, in both cases, the measured data return a linear
LFER plot. In analogy to what previously discussed in protein
folding (Fersht, 2004), this finding is a hallmark of co-operativity
and suggests that not only the residues located in the binding
pocket, but all the probed residues taken are involved in the
binding of the ligand.
It is of interest to compare the dependence of the
plots measured for wild-type Gab2448−460 and Gab2448−460
M457A. In fact, whilst the apparent α value for the TS of
N-SH2 upon binding with Gab2448−460 is 0.44 ± 0.04, in
the case of Gab2448−460 M457A we measured a value of
0.20 ± 0.09. This finding would suggest that the M457A
mutation may influence the structure of the transition state
of N-SH2 in the binding reaction, suggesting that this
protein may be characterized by a remarkable structural
malleability that is dictated by the ligand. Because these
differences appear however just above the limit of the
experimental detection, to further validate this intriguing
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FIGURE 3 | Linear Free Energy Relationship plots (LFER) obtained from the analysis of kinetic data for the binding of N-SH2 domain with Gab2448-460 (A – black full
circles and black line) and with Gab2448-460 M457A (B – gray empty circles and gray broken line). Lines represent the best fit to a linear equation.
scenario we resorted to perform NMR experiments with the two
different ligands.
NMR
We then probed at an atomic resolution the structural
malleability of N-SH2 using nuclear magnetic resonance (NMR).
The sharp and well-dispersed backbone amide resonances in the
1H-15N HSQC of N-SH2 in the free state (Figure 4A, in red)
indicate that the protein is well folded under the experimental
conditions employed in plastico. To obtain residue-specific
information from these spectra, we assigned the resonances of the
protein backbone using a combination of 3D spectra, including
CBCA(CO)NH, HNCACB, HNCO, HN(CA)CO, which were
analyzed using a computer-aided procedure as described in Fusco
et al. (2012). The assigned 1H-15N HSQC was employed to
map the conformational changes and interaction surfaces of
15N labeled N-SH2 upon binding with increasing amounts of
unlabeled Gab2448−460 or Gab2448−460 M457A in a titration
experiment.
The resulting Chemical Shift Perturbation (CSP) is an
established method to study protein-protein interactions, as it
enables following the perturbations on the chemical environment
of single residues upon ligand binding. Since changes in chemical
shifts are very sensitive to structural changes, comparison of
HSQC spectra of free and bound state of a protein may reveal
important information about the residues involved in the process.
In fact, whilst major changes are expected for residues that are in
the binding interface, conformational changes occurring on distal
residues, not directly involved in binding, may be diagnostic for
allosteric communication in the protein.
The comparison between the HSQC of the N-SH2 in the
free and in the bound state with Gab2448−460 shows marked
chemical shift differences, indicating significant perturbation of
the conformational properties of N-SH2 in the free and in the
bound state (Figure 4A). Analogous results have been obtained
for the binding of Gab2448−460 M457A (Figure 4B) with major
chemical shift changes observed as a result of this interaction.
CSP analysis clearly indicates the nature of the cooperative
mechanism of binding of N-SH2 domain with Gab2448−460 and
Gab2448−460 M457A. This result provides further evidence that
the LFER linearity is due to a global structural perturbation of
the protein domain upon binding. Interestingly, the comparison
of the peak shifts in the bound states with Gab2448−460 and
Gab2448−460 M457A evidences that the mutation occurring in the
ligand affects the plasticity of N-SH2 in the complex (Figure 4C).
Our results suggest that the interaction of M457 with the binding
site of N-SH2 generates a structural response in distal residues
of the protein. This scenario implies the presence of an allosteric
network in N-SH2 that finely regulates the binding properties and
conformations of SH2.
Double Mutant Cycles
Protein allostery may be defined as the regulation of a given
protein at a site other than the active (or binding) site. Allosteric
regulation can be cryptic and escape characterization, occurring
in the absence of major conformational changes and involving
thermodynamic interactions of single distal residues. A powerful
methodology to quantitatively calculate the interaction involved
in such elusive allosteric regulations is to measure the energetic
coupling between the ligand and residues that are not directly
located in the binding pocket.
Double mutant cycle is a very effective strategy to infer
energetic coupling and is based on the synergic employment
of mutagenesis and binding experiments (Horovitz and Fersht,
1990). Thus, to investigate the selectivity of N-SH2 domain, we
resorted to investigate the energetic coupling between its residues
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FIGURE 4 | (A) Changes in the 1H-15N-HSQC spectra of free N-SH2 (red peaks) and N-SH2 in complex with Gab2448-460 (blue peaks). (B) Changes in the
1H-15N-HSQC spectra of free N-SH2 (red peaks) and N-SH2 in complex with Gab2448-460 M457A (green peaks). (C) Comparison of 1H-15N-HSQC spectra of the
bound states of N-SH2 with the two variants of Gab2 peptide. The analysis reveals that the M457A mutation in the ligand modulates the plasticity of N-SH2 in the
complex.
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and position M457 of Gab2, which represents a key residue in
driving the selectivity of the domain. In analogy to previous
work on other domains (Chi et al., 2008; Gianni et al., 2011),
coupling free energies were calculated by comparing the changes
in free energy obtained for the N-SH2 variants when binding
to Gab2448−460 to those obtained when binding Gab2448−460
M457A, following the formalism:
111G = 11Gmut−wteq Gab2wt −11G
mut−wt
eq Gab2M457A
When 111G = 0 the (de)stabilization of the bound state due
to the point mutation in N-SH2 when binding to Gab2448−460
equals the one occurring in the binding with Gab2448−460
M457A, meaning that M457 is not energetically coupled to the
mutated residue in N-SH2. On the contrary, a 111G 6= 0
implies that the two positions interact energetically. The energetic
couplings for each mutated residue of N-SH2 with M457 of
Gab2 were calculated from kinetic parameters obtained from
the analysis of pseudo-first order binding experiments and are
reported in Table 1. We found that 4 residues (L51, I60, L75,
and P74) reported a 111G > 0.4 kcal mol−1 upon binding
with Gab2 M457A, whilst for residues L35, T48, L59, L99 we
could not detect binding. It is of particular interest to analyse
the structural distribution of the residues that are affected by
M457A mutation (Figure 5). In fact, while T48, L59, I60, and
L99 are located in the binding site, L35, L51, P74, L75 are
far from the binding pocket. These results, under the light of
NMR data and LFER analysis, evidence the presence of an
allosteric network in the N-SH2 domain that involve the whole
domain, suggesting a key role for these specific residues in
modulating the recognition of M457 of Gab2 and the affinity
for the substrate.
DISCUSSION
In spite of their importance for cell physiology, there is lack
of information pertaining the details of the mechanism of
binding of SH2 domains. In this paper, we provided a detailed
experimental characterization of the binding of N-SH2 to one of
its physiological ligands and detected an unexpected structural
plasticity. This effect was monitored both directly, by NMR by
comparing the free structure with those of the bound states with
two different ligands, and indirectly, by analyzing the effects of
mutagenesis on the binding capability of the domain. NMR data
reported subtle conformational changes in free and bound states.
These minor changes in chemical shifts, supported by LFER and
111G analysis, are indicative of a fine allosteric regulation of
the binding mechanism.
It is of interest to compare our findings with those obtained
on the SH2 domain from Itk. In fact, in the latter, it was
demonstrated binding to be regulated by peptidil-prolyl cis-
trans isomerization (Mallis et al., 2002; Breheny et al., 2003;
Pletneva et al., 2006; Severin et al., 2009). These findings appear
to contrast the results reported in our work, which suggests that
N-SH2 is characterized by a malleable structure, with binding
being mediated by a diffused network involving several residues
not directly located in the binding pocket, as mirrored by the
FIGURE 5 | Structural distribution of the residues (highlighted in red on N-SH2
structure) that are energetically coupled with M residue part of the pY-X-X-M
consensus that is specifically recognized by N-SH2, and finely modulate the
affinity of the domain for its natural binding partners (see text for details).
Because of the unavailability of the N-SH2:Gab2 complex structure, a different
ligand is represented in black (cKit) only to pinpoint the position of the binding
pocket of N-SH2. (PDB: 2IUH).
linearity of the LFER plot. Remarkably, in stark contrast to what
observed in the case of the SH2 domain from Itk, a quantitative
analysis of our NMR data revealed no evidence for peptidil-prolyl
cis-trans isomerization upon binding; therefore highlighting a
completely different scenario. However, it is important to observe
that P74 appears to retain a role in the recognition of M457
of Gab2, reporting a 111G = 0.79 ± 0.12 kcal mol−1. Thus,
this residue, while maintaining a cis conformation both in the
free and bound states, nevertheless participates to the long
range energetic network modulating binding. Interestingly, P74
is conserved in both N-SH2 and C-SH2 domains of PI3K, that
are both known to recognize the pY-X-X-M consensus sequence
(Dornan and Burke, 2018).
Long allosteric networks regulating binding reactions have
been observed for different adaptor protein domains, such as
PDZ and SH3 domains (Gianni et al., 2011; Malagrinò et al.,
2019). Taken together with the experiments reported in this work,
it appears that this mechanism of regulation may be typical of
protein families that share the same topology but nevertheless
must bind selectively specific ligands in the complex cellular
environment. It has been demonstrated that SH2 domains can
bind several peptides presenting different aminoacidic sequences
containing a phosphotyrosine, with affinities differing of some
orders of magnitude (Ladbury and Arold, 2000). We suggest that
the conformational plasticity highlighted in our work, mediated
by long range interactions, represents an additional mechanism
of regulation of the SH2 moiety, tuning the selectivity of the
domain, while maintaining a rather conserved topology and
binding pocket. Future work on other SH2 domains will provide
additional information about the generality of the allosteric
regulation of the binding properties of SH2 domain family.
Frontiers in Molecular Biosciences | www.frontiersin.org 8 May 2020 | Volume 7 | Article 89
fmolb-07-00089 May 10, 2020 Time: 19:17 # 9
Visconti et al. Dynamic Regulation of Allosteric Networks
DATA AVAILABILITY STATEMENT
All datasets generated for this study are included in
article/supplementary material.
AUTHOR CONTRIBUTIONS
LV, AD, and SG designed the research. LV, AT, JJ, FM,
and FT performed the research. LV and AT wrote the first
version of the manuscript. All the authors analyzed data and
revised the manuscript.
FUNDING
Work partly supported by grants from the Italian Ministero
dell’Istruzione dell’UniversitaÌ e della Ricerca (Progetto
di Interesse Invecchiamento to SG), Sapienza University
of Rome (B52F16003410005, RP11715C34AEAC9B, and
RM1181641C2C24B9 to SG), the Associazione Italiana per la
Ricerca sul Cancro (Individual Grant – MFAG 2016, 18701
to SG) the Istituto Pasteur Italia (Teresa Ariaudo Research
Project 2018 to AT). FM is the recipient of a FIRC-AIRC
fellowship. Work partly supported by Medical Research Council
(MR/R000255/1 to AD).
REFERENCES
Bentires-Alj, M., Gil, S. G., Chan, R., Wang, Z. C., Wang, Y., Imanaka, N., et al.
(2006). A role for the scaffolding adapter GAB2 in breast cancer. Nat. Med. 12,
114–121. doi: 10.1038/nm1341
Bhattacharyya, R. P., Reményi, A., Yeh, B. J., and Lim, W. A. (2006). Domains,
motifs, and scaffolds: the role of modular interactions in the evolution and
wiring of cell signaling circuits. Annu. Rev. Biochem. 75, 655–680. doi: 10.1146/
annurev.biochem.75.103004.142710
Breheny, P. J., Laederach, A., Fulton, D. B., and Andreotti, A. H. (2003). Ligand
specificity modulated by prolyl imide bond Cis/Trans isomerization in the Itk
SH2 domain: a quantitative NMR study. J. Am. Chem. Soc. 125, 15706–15707.
doi: 10.1021/ja0375380
Chi, C. N., Elfström, L., Shi, Y., Snäll, T., Engström, A., and Jemth, P. (2008).
Reassessing a sparse energetic network within a single protein domain.
Proc. Natl. Acad. Sci. U.S.A. 105, 4679–4684. doi: 10.1073/pnas.071173
2105
Ding, C. B., Yu, W. N., Feng, J. H., and Luo, J. M. (2015). Structure and function
of Gab2 and its role in cancer (Review). Mol. Med. Rep. 12, 4007–4014. doi:
10.3892/mmr.2015.3951
Dornan, G. L., and Burke, J. E. (2018). Molecular mechanisms of human disease
mediated by oncogenic and primary immunodeficiency mutations in class IA
phosphoinositide 3-kinases. Front. Immunol. 9:575. doi: 10.3389/fimmu.2018.
00575
Eaton, W. A., Henry, E. R., and Hofrichter, J. (1991). Application of linear free
energy relations to protein conformational changes: the quaternary structural
change of hemoglobin. Proc. Natl. Acad. Sci. U.S.A. 88, 4472–4475. doi: 10.1073/
pnas.88.10.4472
Engelman, J. A., Luo, J., and Cantley, L. C. (2006). The evolution of
phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat.
Rev. Genet. 7, 606–619. doi: 10.1038/nrg1879
Fersht, A. R. (2004). Relationship of Leffler (Bronsted) alpha values and protein
folding Phi values to position of transition-state structures on reaction
coordinates. Proc. Natl. Acad. Sci. U.S.A. 101, 14338–14342. doi: 10.1073/pnas.
0406091101
Fersht, A. R., and Sato, S. (2004). Phi-value analysis and the nature of protein-
folding transition states. Proc. Natl. Acad. Sci. U.S.A. 101, 7976–7981. doi:
10.1073/pnas.0402684101
Fuentes, E. J., Gilmore, S. A., Mauldin, R. V., and Lee, A. L. (2006). Evaluation
of energetic and dynamic coupling networks in a PDZ domain protein. J. Mol.
Biol. 364, 337–351. doi: 10.1016/j.jmb.2006.08.076
Fusco, G., De Simone, A., Hsu, S.-T. D., Bemporad, F., Vendruscolo, M., Chiti,
F., et al. (2012). 1H, 13C and 15N resonance assignments of human muscle
acylphosphatase. Biomol. NMR Assign. 6, 27–29. doi: 10.1007/s12104-011-
9318-1
Gangopadhyay, K., Manna, B., Roy, S., Kumari, S., Debnath, O., Chowdhury,
S., et al. (2020). An allosteric hot spot in the tandem-SH2 domain of
ZAP-70 regulates T-cell signaling. Biochem. J. 477, 1287–1308. doi: 10.1042/
BCJ20190879
Gianni, S., Haq, S. R., Montemiglio, L. C., Jürgens, M. C., Engström, Å, Chi, C. N.,
et al. (2011). Sequence-specific long range networks in PSD-95/discs large/ZO-1
(PDZ) domains tune their binding selectivity. J. Biol. Chem. 286, 27167–27175.
doi: 10.1074/jbc.M111.239541
Horovitz, A., and Fersht, A. R. (1990). Strategy for analysing the co-operativity of
intramolecular interactions in peptides and proteins. J. Mol. Biol. 214, 613–617.
doi: 10.1016/0022-2836(90)90275-Q
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., and Waterfield,
M. D. (2001). Cellular function of phosphoinositide 3-kinases: implications for
development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17, 615–675.
doi: 10.1146/annurev.cellbio.17.1.615
Ke, Y., Wu, D., Princen, F., Nguyen, T., Pang, Y., Lesperance, J., et al. (2007). Role
of Gab2 in mammary tumorigenesis and metastasis. Oncogene 26, 4951–4960.
doi: 10.1038/sj.onc.1210315
Kern, D., and Zuiderweg, E. R. P. (2003). The role of dynamics in allosteric
regulation. Curr. Opin. Struct. Biol. 13, 748–757. doi: 10.1016/j.sbi.2003.10.008
Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., and Pawson, T. (1991). SH2
and SH3 domains: elements that control interactions of cytoplasmic signaling
proteins. Science 252, 668–674. doi: 10.1126/science.1708916
Kumawat, A., and Chakrabarty, S. (2017). Hidden electrostatic basis of dynamic
allostery in a PDZ domain. Proc. Natl. Acad. Sci. U.S.A. 114, E5825–E5834.
doi: 10.1073/pnas.1705311114
Kurochkina, N., and Guha, U. (2013). SH3 domains: modules of protein-protein
interactions. Biophys. Rev. 5, 29–39. doi: 10.1007/s12551-012-0081-z
Ladbury, J. E., and Arold, S. (2000). Searching for specificity in SH domains. Chem.
Biol. 7, R3–R8. doi: 10.1016/s1074-5521(00)00067-3
Lappalainen, I., Thusberg, J., Shen, B., and Vihinen, M. (2008). Genome wide
analysis of pathogenic SH2 domain mutations. Proteins 72, 779–792. doi: 10.
1002/prot.21970
Lee, S. H., Jeong, E. G., Nam, S. W., Lee, J. Y., Yoo, N. J., and Lee, S. H.
(2007). Increased expression of Gab2, a scaffolding adaptor of the tyrosine
kinase signalling, in gastric carcinomas. Pathology 39, 326–329. doi: 10.1080/
00313020701329773
Leffler, J. E. (1953). Parameters for the description of transition states. Science 117,
340–341. doi: 10.1126/science.117.3039.340
Lockless, S. W., and Ranganathan, R. (1999). Evolutionarily conserved pathways of
energetic connectivity in protein families. Science 286, 295–299. doi: 10.1126/
science.286.5438.295
Macias, M. J., Hyvönen, M., Baraldi, E., Schultz, J., Sudol, M., Saraste, M.,
et al. (1996). Structure of the WW domain of a kinase-associated protein
complexed with a proline-rich peptide. Nature 382, 646–649. doi: 10.1038/382
646a0
Malagrinò, F., Troilo, F., Bonetti, D., Toto, A., and Gianni, S. (2019). Mapping the
allosteric network within a SH3 domain. Sci. Rep. 9:8279. doi: 10.1038/s41598-
019-44656-8
Mallis, R. J., Brazin, K. N., Fulton, D. B., and Andreotti, A. H. (2002). Structural
characterization of a proline-driven conformational switch within the Itk SH2
domain. Nat. Struct. Biol. 9, 900–905. doi: 10.1038/nsb864
Motlagh, H. N., Wrabl, J. O., Li, J., and Hilser, V. J. (2014). The ensemble nature of
allostery. Nature 508, 331–339. doi: 10.1038/nature13001
Neel, B. G., Gu, H., and Pao, L. (2003). The ’Shp’ing news: SH2 domain-containing
tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28, 284–293. doi:
10.1016/S0968-0004(03)00091-4
Frontiers in Molecular Biosciences | www.frontiersin.org 9 May 2020 | Volume 7 | Article 89
fmolb-07-00089 May 10, 2020 Time: 19:17 # 10
Visconti et al. Dynamic Regulation of Allosteric Networks
Nolte, R. T., Eck, M. J., Schlessinger, J., Shoelson, S. E., and Harrison, S. C. (1996).
Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its
phosphopeptide complexes. Nat. Struct. Biol. 3, 364–374. doi: 10.1038/nsb0496-
364
Pawson, T., and Scott, J. D. (1997). Signaling through scaffold, anchoring, and
adaptor proteins. Science 278, 2075–2080. doi: 10.1126/science.278.5346.2075
Payne, G., Stolz, L. A., Pei, D., Band, H., Shoelson, S. E., and Walsh, C. T. (1994).
The phosphopeptide-binding specificity of Src family SH2 domains. Chem. Biol.
1, 99–105. doi: 10.1016/1074-5521(94)90047-7
Pletneva, E. V., Sundd, M., Fulton, D. B., and Andreotti, A. H. (2006). Molecular
details of Itk activation by prolyl isomerization and phospholigand binding: the
NMR structure of the Itk SH2 domain bound to a phosphopeptide. J. Mol. Biol.
357, 550–561. doi: 10.1016/j.jmb.2005.12.073
Schaffhausen, B. (1995). SH2 domain structure and function. Biochim. Biophys.
Acta 1242, 61–75. doi: 10.1016/0304-419x(95)00004-y
Severin, A., Joseph, R. E., Boyken, S., Fulton, D. B., and Andreotti, A. H. (2009).
Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk
SH3 domain. J. Mol. Biol. 387, 726–743. doi: 10.1016/j.jmb.2009.02.012
Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G.,
et al. (1993). SH2 domains recognize specific phosphopeptide sequences. Cell
72, 767–778. doi: 10.1016/0092-8674(93)90404-e
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H.,
et al. (2001). Mutations in PTPN11, encoding the protein tyrosine phosphatase
SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465–468. doi: 10.1038/ng772
Teyra, J., Sidhu, S. S., and Kim, P. M. (2012). Elucidation of the binding preferences
of peptide recognition modules: SH3 and PDZ domains. FEBS Lett. 586,
2631–2637. doi: 10.1016/j.febslet.2012.05.043
Toney, M. D., and Kirsch, J. F. (1989). Direct Brønsted analysis of the restoration
of activity to a mutant enzyme by exogenous amines. Science 243, 1485–1488.
doi: 10.1126/science.2538921
Tsutsui, Y., Deredge, D., Wintrode, P. L., and Hays, F. A. (2016). Imatinib
binding to human c-Src is coupled to inter-domain allostery and suggests
a novel kinase inhibition strategy. Sci. Rep. 6:30832. doi: 10.1038/srep3
0832
Visconti, L., Malagrinò, F., Toto, A., and Gianni, S. (2019). The kinetics of folding
of the NSH2 domain from p85. Sci. Rep. 9:4058. doi: 10.1038/s41598-019-40
480-2
Waksman, G., Kominos, D., Robertson, S. C., Pant, N., Baltimore, D., Birge, R. B.,
et al. (1992). Crystal structure of the phosphotyrosine recognition domain
SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358,
646–653. doi: 10.1038/358646a0
Waksman, G., Shoelson, S. E., Pant, N., Cowburn, D., and Kuriyan,
J. (1993). Binding of a high affinity phosphotyrosyl peptide to
the Src SH2 domain: crystal structures of the complexed and
peptide-free forms. Cell 72, 779–790. doi: 10.1016/0092-8674(93)9
0405-f
Xu, X. L., Wang, X., Chen, Z. L., Jin, M., Yang, W., Zhao, G. F., et al. (2011).
Overexpression of Grb2-associated binder 2 in human lung cancer. Int. J. Biol.
Sci. 7, 496–504. doi: 10.7150/ijbs.7.496
Zarrinpar, A., Park, S.-H., and Lim, W. A. (2003). Optimization of specificity in a
cellular protein interaction network by negative selection. Nature 426, 676–680.
doi: 10.1038/nature02178
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Visconti, Toto, Jarvis, Troilo, Malagrinò, De Simone and Gianni.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Molecular Biosciences | www.frontiersin.org 10 May 2020 | Volume 7 | Article 89
